MedTrace Logo

Optimal Dose of Early Intervention to Prevent PTSD

NCT01959620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2017-07-21

No results posted yet for this study

Summary

The overall aim of this study is to determine the optimal dose, 3-session exposure intervention versus 1-session exposure intervention compared to no treatment, for the delivery of exposure therapy in the immediate aftermath of trauma for preventing the development of posttraumatic stress disorder.

Conditions

Interventions

BEHAVIORAL

1-Session Exposure Therapy

One exposure therapy session lasting one hour

BEHAVIORAL

3-Session Exposure Therapy

Three exposure therapy sessions lasting one hour each, delivered one week apart

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Barbara O. Rothbaum, PhD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01959620 on ClinicalTrials.gov